Decitabine and Talazoparib in Untreated AML and R/R AML
Clinical trial NCT02878785 · COMPLETED
Trial details
- NCT number
- NCT02878785
- Sponsor
- University of Maryland, Baltimore
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2020-01-05
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.